Skip to main content
. 2023 Feb 17;16(2):315. doi: 10.3390/ph16020315

Figure 3.

Figure 3

Summary of various physical and biological parameters associated with nanocarrier systems, like (A) size, (B) shape, (C) surface charge, (D) tumor phenotype, and (E) targeting ligand density, that potentially influence their in vivo pharmacokinetics and should be considered carefully when designing nanotheranostic systems.